Cordis Endovascular Systems (US) files patent suit against Target:
This article was originally published in Clinica
Cordis Endovascular Systems (US) has filed suit in the San Jose District Court against Target Therapeutics (US), alleging infringement of its patents on microcatheters, guidewires and guiding catheters used to diagnose and treat disorders of the brain, liver and other internal organs (US Patent Nos 4,596,563; 4,846,186; and 5,171,232). Target products alleged to infringe the patents, which were filed in March 1984, include lines of Tracker and FasTracker microcatheters, Dasher guidewires and FasGuide guiding catheters.
You may also be interested in...
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.